Development of a new ART technology utilizing cytoplasmic transfer/replacement
Not Applicable
- Conditions
- Infertile couples undergoing ICSI
- Registration Number
- JPRN-UMIN000047678
- Lead Sponsor
- Tohoku university graduate school of medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up continuing
- Sex
- Female
- Target Recruitment
- 150
Inclusion Criteria
Not provided
Exclusion Criteria
Patient who has infections, such as hepatitis B and C, syphilis, HIV and other virus carrier. Patient who has been registered in other clinical trial In case doctor in charge decided inappropriate.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Feasibility of utilization of female genome in 1st polar body of freeze-thaw human eggs in ART by combination of polar body transfer/maternal spindle transfer techniques.
- Secondary Outcome Measures
Name Time Method In vitro development of parthenogenetically activated embryos, ATP and respiratory measurement on developed blastocyst, Spindle morphology and expression of functional proteins.